Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.07M Sell
5,632
-17
-0.3% -$5.82K 0.64% 23
2026
Q1
$1.92M Sell
5,649
-18
-0.3% -$6.42K 0.64% 24
2025
Q4
$1.82M Hold
5,667
0.62% 27
2025
Q3
$1.69M Sell
5,667
-108
-2% -$31.3K 0.63% 26
2025
Q2
$1.68M Buy
5,775
+2
+0% +$567 0.66% 24
2025
Q1
$1.67M Sell
5,773
-13
-0.2% -$3.84K 0.78% 19
2024
Q4
$1.57M Sell
5,786
-68
-1% -$20.2K 0.69% 23
2024
Q3
$1.87M Hold
5,854
0.88% 16
2024
Q2
$1.85M Buy
5,854
+72
+1% +$21.2K 0.92% 16
2024
Q1
$1.54M Hold
5,782
0.85% 18
2023
Q4
$1.75M Buy
5,782
+2
+0% +$545 1.16% 15
2023
Q3
$1.54M Sell
5,780
-10
-0.2% -$2.5K 1.17% 9
2023
Q2
$1.37M Sell
5,790
-10
-0.2% -$2.32K 0.97% 13
2023
Q1
$1.47M Sell
5,800
-11
-0.2% -$2.7K 1.1% 10
2022
Q4
$1.59M Buy
5,811
+44
+0.8% +$11.8K 1.2% 9
2022
Q3
$1.3M Sell
5,767
-3
-0.1% -$727 1.13% 10
2022
Q2
$1.43M Sell
5,770
-94
-2% -$23K 1.12% 11
2022
Q1
$1.4M Buy
5,864
+18
+0.3% +$4.14K 1.06% 13
2021
Q4
$1.3M Buy
+5,846
New +$1.23M 1.02% 13

Other funds holding AMGN

MKT Advisors's AMGN Position: Q2 2026 in Review

MKT Advisors reduced its Amgen (AMGN) stake by 0.3% in Q2 2026, selling an estimated $5.82K and leaving 5,632 shares worth $2.07M. The position accounts for 0.64% of the portfolio, ranked #23.

MKT Advisors first reported a position in AMGN in Q4 2021 and has held it in 19 quarters since. 1,543 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • MKT Advisors held 5,632 shares of Amgen worth $2.07M as of Q2 2026.
  • MKT Advisors sold 17 Amgen shares in Q2 2026, an estimated $5.82K.
  • Amgen made up 0.64% of MKT Advisors's portfolio in Q2 2026, its #23 holding.
  • MKT Advisors first reported a position in Amgen in Q4 2021 and has held it in 19 quarters since.
  • 1,543 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on MKT Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.